<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01365793</url>
  </required_header>
  <id_info>
    <org_study_id>230233</org_study_id>
    <secondary_id>U01HD062417</secondary_id>
    <nct_id>NCT01365793</nct_id>
  </id_info>
  <brief_title>Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis</brief_title>
  <official_title>Fluid Therapy and Cerebral Injury in Pediatric Diabetic Ketoacidosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will conduct a randomized controlled trial comparing four different
      intravenous (IV) fluid treatment protocols for pediatric diabetic ketoacidosis (DKA). Two
      rates of rehydration will be compared; a more rapid rate and a slower rate. Within each of
      these two basic rehydration protocols, the investigators will vary the type of rehydration
      fluid used (0.9% saline or 0.45% saline). The investigators will compare the different
      treatments by conducting assessments of neurological injury, by measuring the frequency of
      significant cerebral edema, and by measuring long-term neurocognitive function.

      These studies will allow us to determine whether variations in IV fluid treatment protocols
      affect acute neurological outcomes of DKA. Additionally, they will provide important data
      regarding the impact of DKA and DKA treatment on long-term neurocognitive function in
      children. In this way, the investigators hope to identify a more ideal fluid management
      strategy for children with DKA.

      Previous studies have suggested that DKA may cause blood flow to the brain to be reduced and
      that brain injury might result from this reduction in blood flow and/or the effects of
      re-establishment of normal blood flow during DKA treatment with insulin and iv fluids. The
      investigators hypothesize that more rapidly re-establishing normal blood flow to the brain
      during DKA, by giving fluids more rapidly and using fluids with a higher sodium (salt)
      content, will help to minimize brain injury caused by DKA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      These data will be compared to observational data from children with type 1 diabetes without
      DKA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the Number of Participants With Glasgow Coma Score (GCS) &lt; 14 Within the First 24 Hours of Treatment for Diabetic Ketoacidosis (DKA)</measure>
    <time_frame>24 hours</time_frame>
    <description>The primary outcome is the binary indicator that a patient's GCS score drops below 14 (i.e. abnormal score) within the first 24 hours of treatment of DKA. There will be two treatment factors: sodium concentration of re-hydration fluids and rate of rehydration. These effects will be tested separately, using the Mantel-Haenszel chi-square test, stratified by hospital, and by the other main factor.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of Clinically Apparent Brain Injury</measure>
    <time_frame>24 hours</time_frame>
    <description>Deterioration in neurological status requiring interventions such as hyperosmolar therapy or endotracheal intubation, or resulting in death. This outcome was determined by an adjudication committee.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hourly Improvement in Forward and Backward Digit Span Scores During DKA Treatment (Mean Difference Per Hour)</measure>
    <time_frame>24 hours</time_frame>
    <description>The Digit Span subtest is adapted from the Wechsler Intelligence Scale for Children, 4th version (WISC-IV) and it assesses working memory. It consists of a Digit Span Forward task in which individuals are asked to repeat numbers in the same sequence as they were presented verbally and a Digit Span Backward task in which participants repeat the numbers in the reversed order to which they were heard. Each task yields a score ranging from 0 to 16. Higher scores represent better outcomes for this test. The trajectory of digit span scores during the course of the hospitalization was used to assess improvements in mental status and whether these varied systematically as a function of treatment protocol. Digit span measurements were collected every four hours during waking hours (7AM to 10PM). The measure analyzed is the average linear change in scores between enrollment and either 24-hours or DKA resolution, whichever occurred first.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Scores on Tests of Memory Capacity 3 Months After Recovery From DKA.</measure>
    <time_frame>3 months</time_frame>
    <description>Contextual memory was assessed via color and spatial-position tasks. Color-Task: black-ink items on a white square background were shown on a computer screen with a colored border. Subjects were asked to remember the item and the item's border color. Items were shown for 1 second, followed by a 1-second interval in which a fixation point was shown. Then, subjects were given a self-paced recognition test including studied drawings and new drawings shown in random order with no color border. Subjects determined if they had seen the drawing before. For recognized drawings, subjects reported the previously shown border color. Spatial-Position task: identical to the color task except that the items instead varied in their spatial position on the computer screen. The item-context association rate is the rate of correct item-color and item-spatial position recalled over the total of previously viewed items correctly recognized. Score range: 0-1 with higher scores indicating a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intelligence Quotient (IQ) Testing</measure>
    <time_frame>3 months</time_frame>
    <description>IQ was assessed with the WASI (6-18 year olds) or WPPSI-III (3-5 year olds) at the 3 month follow-up visit. The Wechsler Abbreviated Scale of Intelligence (WASI) is a measure of IQ designed for individuals aged 6 to 89. The WASI includes four subtests; the Block Design and Matrix Reasoning tests measure Performance IQ, and the Vocabulary and Similarities tests measure Verbal IQ. Full scale IQ was computed from these scores and used for analyses. Scores typically vary from 75 to 135 with higher scores representing a better outcome.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">1389</enrollment>
  <condition>Cerebral Edema</condition>
  <condition>Diabetic Ketoacidosis</condition>
  <arm_group>
    <arm_group_label>Rapid rehydration using 0.45% saline replacement fluid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will involve more rapid intravenous fluid treatment which will include a second 10cc/Kg bolus of 0.9% saline and assume a 10% fluid deficit. 0.45% saline will be used as the replacement fluid for this arm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rapid rehydration using 0.9% saline replacement fluid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will involve more rapid intravenous fluid treatment which will include a second 10cc/Kg bolus of 0.9% saline and assume a 10% fluid deficit. 0.9% saline will be used as the replacement fluid.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Slower rehydration using 0.45% saline intravenous fluid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will involve slower rehydration (assumed 5% fluid deficit and no additional fluid bolus) with 0.45% saline used as the replacement fluid.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Slower rehydration using 0.9% saline intravenous fluid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will involve slower rehydration (assumed 5% fluid deficit and no additional fuid bolus) with 0.9% saline used as the replacement fluid.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.45% saline replacement fluid</intervention_name>
    <description>10cc/Kg bolus of 0.9% saline followed by 0.45% saline used as the replacement fluid</description>
    <arm_group_label>Rapid rehydration using 0.45% saline replacement fluid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% saline replacement fluid</intervention_name>
    <description>10cc/Kg bolus of 0.9% saline followed by 0.9% saline used as the replacement fluid.</description>
    <arm_group_label>Rapid rehydration using 0.9% saline replacement fluid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.45% saline intravenous fluid</intervention_name>
    <description>0.45% saline fluid</description>
    <arm_group_label>Slower rehydration using 0.45% saline intravenous fluid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% saline Intravenous fluid</intervention_name>
    <description>0.9% saline fluid</description>
    <arm_group_label>Slower rehydration using 0.9% saline intravenous fluid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  must present or be transferred to a participating emergency department

          -  age less than 18 years

          -  diagnosis of DKA

               -  serum glucose or fingerstick glucose concentration &gt;300 mg/dL

               -  venous pH &lt; 7.25 OR serum bicarbonate concentration &lt; 15 mmol/L.

        Exclusion Criteria:

          -  patients with underlying neurological disorders or neurocognitive deficits which would
             affect either mental status testing during treatment or subsequent neurocognitive
             testing after recovery

          -  patients who present with concomitant alcohol or drug use, head trauma, meningitis or
             other conditions which might affect neurological function

          -  patients transferred to one of the participating emergency departments after
             initiation of DKA treatment other than one 10cc/kg intravenous bolus of 0.9% saline

          -  patients who are known to be pregnant at time of ED evaluation

          -  patients who have been enrolled in this study twice previously

          -  patients for whom the treating physician believed a specific fluid and electrolyte
             regimen was warranted

          -  patients for whom informed consent could not be obtained within 1 hour after
             completion of the initial fluid bolus, or within 2 hours from initiation of fluids,
             whichever is longer

          -  Patients who have been receiving IV fluids at a maintenance rate or greater (defined
             by the 4-2-1 rule) for more than two hours; OR

          -  Patients for whom it has been more than four hours since DKA therapy (IV fluids, IV
             bolus, or IV insulin) began; OR

          -  Patients who have been given hyperosmolar therapy (i.e. mannitol or 3% normal saline)
             prior to or since arriving at one of the participating PECARN emergency departments;
             OR

          -  Patients for whom the treating physician intends to immediately administer
             hyperosmolar therapy (i.e. mannitol or 3% normal saline); OR

          -  Patients whose baseline GCS is 11 or less.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathan Kuppermann, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicole S Glaser, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, Davis</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alfred I. duPont Hospital for Children</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ann &amp; Robert Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University &amp; St. Louis Children's Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hasbro Children's Hospital/Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Children's Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84158</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.pecarn.org</url>
    <description>Official website of the Pediatric Emergency Care Applied Research Network (PECARN), funded by HRSA/MCHB</description>
  </link>
  <reference>
    <citation>Glaser NS, Ghetti S, Casper TC, Dean JM, Kuppermann N; Pediatric Emergency Care Applied Research Network (PECARN) DKA FLUID Study Group. Pediatric diabetic ketoacidosis, fluid therapy, and cerebral injury: the design of a factorial randomized controlled trial. Pediatr Diabetes. 2013 Sep;14(6):435-46. doi: 10.1111/pedi.12027. Epub 2013 Mar 13.</citation>
    <PMID>23490311</PMID>
  </reference>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 1, 2011</study_first_submitted>
  <study_first_submitted_qc>June 2, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2011</study_first_posted>
  <results_first_submitted>March 5, 2018</results_first_submitted>
  <results_first_submitted_qc>June 19, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">June 25, 2018</results_first_posted>
  <last_update_submitted>June 19, 2018</last_update_submitted>
  <last_update_submitted_qc>June 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cerebral edema</keyword>
  <keyword>diabetic ketoacidosis</keyword>
  <keyword>pediatric diabetes</keyword>
  <keyword>fluid therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Edema</mesh_term>
    <mesh_term>Ketosis</mesh_term>
    <mesh_term>Acidosis</mesh_term>
    <mesh_term>Diabetic Ketoacidosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Rapid Rehydration Using 0.45% Saline Replacement Fluid</title>
          <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
        </group>
        <group group_id="P2">
          <title>Rapid Rehydration Using 0.9% Saline Replacement Fluid</title>
          <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
        </group>
        <group group_id="P3">
          <title>Slower Rehydration Using 0.45% Saline Replacement Fluid</title>
          <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
        </group>
        <group group_id="P4">
          <title>Slower Rehydration Using 0.9% Saline Replacement Fluid</title>
          <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="344"/>
                <participants group_id="P2" count="351"/>
                <participants group_id="P3" count="345"/>
                <participants group_id="P4" count="349"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="342"/>
                <participants group_id="P2" count="344"/>
                <participants group_id="P3" count="338"/>
                <participants group_id="P4" count="347"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Rapid Rehydration Using 0.45% Saline Replacement Fluid</title>
          <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
        </group>
        <group group_id="B2">
          <title>Rapid Rehydration Using 0.9% Saline Replacement Fluid</title>
          <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
        </group>
        <group group_id="B3">
          <title>Slower Rehydration Using 0.45% Saline Replacement Fluid</title>
          <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
        </group>
        <group group_id="B4">
          <title>Slower Rehydration Using 0.9% Saline Replacement Fluid</title>
          <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="344"/>
            <count group_id="B2" value="351"/>
            <count group_id="B3" value="345"/>
            <count group_id="B4" value="349"/>
            <count group_id="B5" value="1389"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>0 to less than 6 years old</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="42"/>
                    <measurement group_id="B4" value="35"/>
                    <measurement group_id="B5" value="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 to less than 18 years old</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="301"/>
                    <measurement group_id="B2" value="309"/>
                    <measurement group_id="B3" value="303"/>
                    <measurement group_id="B4" value="314"/>
                    <measurement group_id="B5" value="1227"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="179"/>
                    <measurement group_id="B2" value="187"/>
                    <measurement group_id="B3" value="187"/>
                    <measurement group_id="B4" value="186"/>
                    <measurement group_id="B5" value="739"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="165"/>
                    <measurement group_id="B2" value="164"/>
                    <measurement group_id="B3" value="158"/>
                    <measurement group_id="B4" value="163"/>
                    <measurement group_id="B5" value="650"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Race</title>
              <category_list>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="235"/>
                    <measurement group_id="B2" value="232"/>
                    <measurement group_id="B3" value="247"/>
                    <measurement group_id="B4" value="243"/>
                    <measurement group_id="B5" value="957"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="73"/>
                    <measurement group_id="B2" value="82"/>
                    <measurement group_id="B3" value="68"/>
                    <measurement group_id="B4" value="63"/>
                    <measurement group_id="B5" value="286"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="23"/>
                    <measurement group_id="B5" value="72"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Ethnicity</title>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="49"/>
                    <measurement group_id="B4" value="69"/>
                    <measurement group_id="B5" value="228"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino, Other, or Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="296"/>
                    <measurement group_id="B2" value="289"/>
                    <measurement group_id="B3" value="296"/>
                    <measurement group_id="B4" value="280"/>
                    <measurement group_id="B5" value="1161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>the Number of Participants With Glasgow Coma Score (GCS) &lt; 14 Within the First 24 Hours of Treatment for Diabetic Ketoacidosis (DKA)</title>
        <description>The primary outcome is the binary indicator that a patient's GCS score drops below 14 (i.e. abnormal score) within the first 24 hours of treatment of DKA. There will be two treatment factors: sodium concentration of re-hydration fluids and rate of rehydration. These effects will be tested separately, using the Mantel-Haenszel chi-square test, stratified by hospital, and by the other main factor.</description>
        <time_frame>24 hours</time_frame>
        <population>Patients with a GCS of 14 or 15 at randomization</population>
        <group_list>
          <group group_id="O1">
            <title>Rapid Rehydration Using 0.45% Saline Replacement Fluid</title>
            <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
          </group>
          <group group_id="O2">
            <title>Rapid Rehydration Using 0.9% Saline Replacement Fluid</title>
            <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
          </group>
          <group group_id="O3">
            <title>Slower Rehydration Using 0.45% Saline Replacement Fluid</title>
            <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
          </group>
          <group group_id="O4">
            <title>Slower Rehydration Using 0.9% Saline Replacement Fluid</title>
            <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
          </group>
        </group_list>
        <measure>
          <title>the Number of Participants With Glasgow Coma Score (GCS) &lt; 14 Within the First 24 Hours of Treatment for Diabetic Ketoacidosis (DKA)</title>
          <description>The primary outcome is the binary indicator that a patient's GCS score drops below 14 (i.e. abnormal score) within the first 24 hours of treatment of DKA. There will be two treatment factors: sodium concentration of re-hydration fluids and rate of rehydration. These effects will be tested separately, using the Mantel-Haenszel chi-square test, stratified by hospital, and by the other main factor.</description>
          <population>Patients with a GCS of 14 or 15 at randomization</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="337"/>
                <count group_id="O2" value="345"/>
                <count group_id="O3" value="338"/>
                <count group_id="O4" value="341"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>The study uses a factorial experimental design, and tests two null hypotheses. The first of these hypotheses - the frequency of GCS score declines to &lt;14 is equal between the Rapid Rehydration and Slower Rehydration groups - is reported here. The analysis of the second hypothesis is reported below.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Each statistical test uses stratification to adjust for enrolling hospital, and the arm not being tested (e.g., the test for rapid vs slower rehydration is stratified by 0.45% and 0.9% Saline, and vice versa).</non_inferiority_desc>
            <p_value>0.34</p_value>
            <p_value_desc>The a priori threshold for statistical significance for each of the 2 p-values is 0.025, for an overall significance of 0.50.</p_value_desc>
            <method>Cochran-Mantel-Haenszel</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>The study uses a factorial experimental design, and tests the two null hypotheses. The second of these hypotheses - the frequency of GCS score declines to &lt;14 is equal between the 0.45% Saline group and the 0.90% Saline group - is reported here. The analysis of the first hypothesis is reported above.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Each statistical test uses stratification to adjust for enrolling hospital, and the arm not being tested (e.g., the test for rapid vs slower rehydration is stratified by 0.45% and 0.9% Saline, and vice versa).</non_inferiority_desc>
            <p_value>0.43</p_value>
            <p_value_desc>The a priori threshold for statistical significance for each of the 2 p-values is 0.025, for an overall significance of 0.50.</p_value_desc>
            <method>Cochran-Mantel-Haenszel</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Frequency of Clinically Apparent Brain Injury</title>
        <description>Deterioration in neurological status requiring interventions such as hyperosmolar therapy or endotracheal intubation, or resulting in death. This outcome was determined by an adjudication committee.</description>
        <time_frame>24 hours</time_frame>
        <population>All randomized patients.</population>
        <group_list>
          <group group_id="O1">
            <title>Rapid Rehydration Using 0.45% Saline Replacement Fluid</title>
            <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
          </group>
          <group group_id="O2">
            <title>Rapid Rehydration Using 0.9% Saline Replacement Fluid</title>
            <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
          </group>
          <group group_id="O3">
            <title>Slower Rehydration Using 0.45% Saline Replacement Fluid</title>
            <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
          </group>
          <group group_id="O4">
            <title>Slower Rehydration Using 0.9% Saline Replacement Fluid</title>
            <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Frequency of Clinically Apparent Brain Injury</title>
          <description>Deterioration in neurological status requiring interventions such as hyperosmolar therapy or endotracheal intubation, or resulting in death. This outcome was determined by an adjudication committee.</description>
          <population>All randomized patients.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="344"/>
                <count group_id="O2" value="351"/>
                <count group_id="O3" value="345"/>
                <count group_id="O4" value="349"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hourly Improvement in Forward and Backward Digit Span Scores During DKA Treatment (Mean Difference Per Hour)</title>
        <description>The Digit Span subtest is adapted from the Wechsler Intelligence Scale for Children, 4th version (WISC-IV) and it assesses working memory. It consists of a Digit Span Forward task in which individuals are asked to repeat numbers in the same sequence as they were presented verbally and a Digit Span Backward task in which participants repeat the numbers in the reversed order to which they were heard. Each task yields a score ranging from 0 to 16. Higher scores represent better outcomes for this test. The trajectory of digit span scores during the course of the hospitalization was used to assess improvements in mental status and whether these varied systematically as a function of treatment protocol. Digit span measurements were collected every four hours during waking hours (7AM to 10PM). The measure analyzed is the average linear change in scores between enrollment and either 24-hours or DKA resolution, whichever occurred first.</description>
        <time_frame>24 hours</time_frame>
        <population>All randomized patients with digit span measured during DKA</population>
        <group_list>
          <group group_id="O1">
            <title>Rapid Rehydration Using 0.45% Saline Replacement Fluid</title>
            <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
          </group>
          <group group_id="O2">
            <title>Rapid Rehydration Using 0.9% Saline Replacement Fluid</title>
            <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
          </group>
          <group group_id="O3">
            <title>Slower Rehydration Using 0.45% Saline Replacement Fluid</title>
            <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
          </group>
          <group group_id="O4">
            <title>Slower Rehydration Using 0.9% Saline Replacement Fluid</title>
            <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Hourly Improvement in Forward and Backward Digit Span Scores During DKA Treatment (Mean Difference Per Hour)</title>
          <description>The Digit Span subtest is adapted from the Wechsler Intelligence Scale for Children, 4th version (WISC-IV) and it assesses working memory. It consists of a Digit Span Forward task in which individuals are asked to repeat numbers in the same sequence as they were presented verbally and a Digit Span Backward task in which participants repeat the numbers in the reversed order to which they were heard. Each task yields a score ranging from 0 to 16. Higher scores represent better outcomes for this test. The trajectory of digit span scores during the course of the hospitalization was used to assess improvements in mental status and whether these varied systematically as a function of treatment protocol. Digit span measurements were collected every four hours during waking hours (7AM to 10PM). The measure analyzed is the average linear change in scores between enrollment and either 24-hours or DKA resolution, whichever occurred first.</description>
          <population>All randomized patients with digit span measured during DKA</population>
          <units>Digit Span Change per Hour</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="344"/>
                <count group_id="O2" value="351"/>
                <count group_id="O3" value="345"/>
                <count group_id="O4" value="349"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Digit span recall test Forward slope</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.065" spread="0.010"/>
                    <measurement group_id="O2" value="0.058" spread="0.010"/>
                    <measurement group_id="O3" value="0.046" spread="0.010"/>
                    <measurement group_id="O4" value="0.039" spread="0.010"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Digit span recall test Backward slope</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.052" spread="0.009"/>
                    <measurement group_id="O2" value="0.053" spread="0.009"/>
                    <measurement group_id="O3" value="0.042" spread="0.009"/>
                    <measurement group_id="O4" value="0.043" spread="0.009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Scores on Tests of Memory Capacity 3 Months After Recovery From DKA.</title>
        <description>Contextual memory was assessed via color and spatial-position tasks. Color-Task: black-ink items on a white square background were shown on a computer screen with a colored border. Subjects were asked to remember the item and the item's border color. Items were shown for 1 second, followed by a 1-second interval in which a fixation point was shown. Then, subjects were given a self-paced recognition test including studied drawings and new drawings shown in random order with no color border. Subjects determined if they had seen the drawing before. For recognized drawings, subjects reported the previously shown border color. Spatial-Position task: identical to the color task except that the items instead varied in their spatial position on the computer screen. The item-context association rate is the rate of correct item-color and item-spatial position recalled over the total of previously viewed items correctly recognized. Score range: 0-1 with higher scores indicating a better outcome.</description>
        <time_frame>3 months</time_frame>
        <population>All randomized subjects aged 6 years old and older with 3-month follow-up and successful completion of memory score tests, and d-prime (a measure of chance agreement) &gt;0.50</population>
        <group_list>
          <group group_id="O1">
            <title>Rapid Rehydration Using 0.45% Saline Replacement Fluid</title>
            <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
          </group>
          <group group_id="O2">
            <title>Rapid Rehydration Using 0.9% Saline Replacement Fluid</title>
            <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
          </group>
          <group group_id="O3">
            <title>Slower Rehydration Using 0.45% Saline Replacement Fluid</title>
            <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
          </group>
          <group group_id="O4">
            <title>Slower Rehydration Using 0.9% Saline Replacement Fluid</title>
            <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Scores on Tests of Memory Capacity 3 Months After Recovery From DKA.</title>
          <description>Contextual memory was assessed via color and spatial-position tasks. Color-Task: black-ink items on a white square background were shown on a computer screen with a colored border. Subjects were asked to remember the item and the item's border color. Items were shown for 1 second, followed by a 1-second interval in which a fixation point was shown. Then, subjects were given a self-paced recognition test including studied drawings and new drawings shown in random order with no color border. Subjects determined if they had seen the drawing before. For recognized drawings, subjects reported the previously shown border color. Spatial-Position task: identical to the color task except that the items instead varied in their spatial position on the computer screen. The item-context association rate is the rate of correct item-color and item-spatial position recalled over the total of previously viewed items correctly recognized. Score range: 0-1 with higher scores indicating a better outcome.</description>
          <population>All randomized subjects aged 6 years old and older with 3-month follow-up and successful completion of memory score tests, and d-prime (a measure of chance agreement) &gt;0.50</population>
          <units>Item-context association rate</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="175"/>
                <count group_id="O2" value="184"/>
                <count group_id="O3" value="178"/>
                <count group_id="O4" value="176"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.60" spread="0.14"/>
                    <measurement group_id="O2" value="0.60" spread="0.14"/>
                    <measurement group_id="O3" value="0.61" spread="0.14"/>
                    <measurement group_id="O4" value="0.60" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intelligence Quotient (IQ) Testing</title>
        <description>IQ was assessed with the WASI (6-18 year olds) or WPPSI-III (3-5 year olds) at the 3 month follow-up visit. The Wechsler Abbreviated Scale of Intelligence (WASI) is a measure of IQ designed for individuals aged 6 to 89. The WASI includes four subtests; the Block Design and Matrix Reasoning tests measure Performance IQ, and the Vocabulary and Similarities tests measure Verbal IQ. Full scale IQ was computed from these scores and used for analyses. Scores typically vary from 75 to 135 with higher scores representing a better outcome.</description>
        <time_frame>3 months</time_frame>
        <population>All randomized subjects aged 3 years and older with 3-month follow-up and successful completion of IQ testing.</population>
        <group_list>
          <group group_id="O1">
            <title>Rapid Rehydration Using 0.45% Saline Replacement Fluid</title>
            <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
          </group>
          <group group_id="O2">
            <title>Rapid Rehydration Using 0.9% Saline Replacement Fluid</title>
            <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
          </group>
          <group group_id="O3">
            <title>Slower Rehydration Using 0.45% Saline Replacement Fluid</title>
            <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
          </group>
          <group group_id="O4">
            <title>Slower Rehydration Using 0.9% Saline Replacement Fluid</title>
            <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Intelligence Quotient (IQ) Testing</title>
          <description>IQ was assessed with the WASI (6-18 year olds) or WPPSI-III (3-5 year olds) at the 3 month follow-up visit. The Wechsler Abbreviated Scale of Intelligence (WASI) is a measure of IQ designed for individuals aged 6 to 89. The WASI includes four subtests; the Block Design and Matrix Reasoning tests measure Performance IQ, and the Vocabulary and Similarities tests measure Verbal IQ. Full scale IQ was computed from these scores and used for analyses. Scores typically vary from 75 to 135 with higher scores representing a better outcome.</description>
          <population>All randomized subjects aged 3 years and older with 3-month follow-up and successful completion of IQ testing.</population>
          <units>IQ points</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="187"/>
                <count group_id="O2" value="201"/>
                <count group_id="O3" value="191"/>
                <count group_id="O4" value="189"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102" spread="12"/>
                    <measurement group_id="O2" value="102" spread="13"/>
                    <measurement group_id="O3" value="102" spread="13"/>
                    <measurement group_id="O4" value="103" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Rapid Rehydration Using 0.45% Saline Replacement Fluid</title>
          <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
        </group>
        <group group_id="E2">
          <title>Rapid Rehydration Using 0.9% Saline Replacement Fluid</title>
          <description>This arm involved more rapid intravenous fluid treatment which included a second 10cc/Kg bolus of 0.9% saline and assumed a 10% fluid deficit. Intravenous fluids were infused to replace half of the estimated fluid deficit over 12 hours and the remaining half over the following 24 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
        </group>
        <group group_id="E3">
          <title>Slower Rehydration Using 0.45% Saline Replacement Fluid</title>
          <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.45% saline was used as the replacement fluid for this arm.</description>
        </group>
        <group group_id="E4">
          <title>Slower Rehydration Using 0.9% Saline Replacement Fluid</title>
          <description>This arm involved slower rehydration (assumed 5% fluid deficit and no additional fluid bolus). Intravenous fluids were infused to replace the estimated deficit over 48 hours, in addition to maintenance fluids. 0.9% saline was used as the replacement fluid for this arm.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="342"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="344"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="338"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatomegaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Acidosis hyperchloraemic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="342"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="344"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="338"/>
                <counts group_id="E4" events="7" subjects_affected="7" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypovolemic shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="112" subjects_at_risk="342"/>
                <counts group_id="E2" subjects_affected="124" subjects_at_risk="344"/>
                <counts group_id="E3" subjects_affected="117" subjects_at_risk="338"/>
                <counts group_id="E4" subjects_affected="129" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Nodal Rythm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="342"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="344"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Ventricular Extrasystoles</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Middle ear effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Eye irritation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Ocular hyperaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="342"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="344"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="338"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Abdominal tenderness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="342"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="344"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="338"/>
                <counts group_id="E4" events="11" subjects_affected="11" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Gastrointestinal sounds abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Gingival pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Glossodynia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="342"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="344"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="338"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Oesophageal discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Oral Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Proctalgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="342"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="344"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="338"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Catheter site inflammation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="342"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Catheter site pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="338"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="344"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="338"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Complication associated with device</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Crying</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Facial pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Infusion site extravasation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Infusion site pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="342"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="344"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="338"/>
                <counts group_id="E4" events="10" subjects_affected="10" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Candida infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Candiduria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Fungal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Lice infestation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Metapneumovirus infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Oral candidiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Otitits media</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Periorbital cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Pharyngitis streptococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Pyuria</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Skin candida</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Tooth infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Urethritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="338"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Vaginal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Vulvovaginal candidiasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Vulvovaginal mycotic infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Vuvlovaginitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Heart injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Medication error</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Amylase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood bicarbonate decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood chloride increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood creatinine phosphokinase decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood glucose decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="344"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="338"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood immunoglobulin A increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood ketone body increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood magnesium decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood osmolarity decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood phosphorus decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood potassium decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood sodium decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood sodium increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood thyroid stimulating hormone increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Blood urea decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Cardiac murmur</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Coma scale abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="344"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Crystal urine present</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QT prolonged</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Electrocardiogram T wave peaked</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Influenza A virus test positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Lipase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Liver function test increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Streptococcus test positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Urinary casts</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Urine analysis abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Urine output decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>White blood cell count increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="338"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Acidosis hyperchloraemic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="342"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="344"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="338"/>
                <counts group_id="E4" events="20" subjects_affected="20" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Alkalosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hyperchloraemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="342"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="342"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="344"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hypernatraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hyperphosphataemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hypertriglyceridaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="342"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="344"/>
                <counts group_id="E3" events="13" subjects_affected="12" subjects_at_risk="338"/>
                <counts group_id="E4" events="17" subjects_affected="15" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="342"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="344"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="338"/>
                <counts group_id="E4" events="16" subjects_affected="15" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hypophagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="342"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="344"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="338"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="342"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Trismus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="29" subjects_affected="29" subjects_at_risk="342"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="344"/>
                <counts group_id="E3" events="23" subjects_affected="23" subjects_at_risk="338"/>
                <counts group_id="E4" events="31" subjects_affected="28" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Irritability</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="342"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="344"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="338"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Incontinence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Vaginal discharge</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Vulvovaginal pruritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="342"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="344"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="338"/>
                <counts group_id="E4" events="9" subjects_affected="9" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Pharyngeal erythema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Stridor</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Tachypnoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Throat irritation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Pruritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="342"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="344"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="338"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Rash erythematous</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Rash pruritic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Skin disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Skin warm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Swelling face</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Flushing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="344"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Peripheral coldness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="338"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="347"/>
              </event>
              <event>
                <sub_title>Poor peripheral circulation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="342"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="344"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="338"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="347"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Fluid infusion rates for this study represent the upper and lower ends of DKA protocols in use. Rates above or below this range were not evaluated. There were fewer patients with GCS decline to &lt;14 than anticipated.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Nathan Kuppermann</name_or_title>
      <organization>University of California, Davis (UC Davis Health)</organization>
      <phone>916-734-1535</phone>
      <email>nkuppermann@ucdavis.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

